Bullish vs. Bearish (1 opinions)
Social Sentiment -0.70
ADAP Forecast and Technical Stock Analysis
Hold candidate since 2019-09-20 PDF
Adaptimmune Therapeutics plc gained 1.14% in the last trading day ( Friday, 20th Sep 2019 ), rising from $1.75 to $1.77 During the day the stock fluctuated 5.33% from a day low at $1.69 to a day high of $1.78. The price has fallen in 5 of the last 10 days , but is still up by 12.74% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 42 182 more shares were traded than the day before. In total, 187 109 shares bought and sold for approximately $331 183.00.
- 30 day high of the ADAP stock price was $2.25 and low was $1.37.
- 90 day high was $4.14 and low was $1.37.
- 52 week high for Adaptimmune Therapeutics plc - $14.54 and low - $1.37.
Adaptimmune Therapeutics plc has broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction there will be support on the roof on the current trend broken, which is $1.75, a level that may pose a second chance to hit a runner. According to fan-theory $3.17 will be the next possible trendtop level and thereby pose a resistance level which may not be broken on the first attempt.
Adaptimmune Therapeutics plc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $1.81. On a fall, the stock will find some support from the long-term average at approximately $1.75. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Wednesday September 18, 2019, which indicates further gains until a new top pivot has been found. Adaptimmune Therapeutics plc has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 57 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Adaptimmune Therapeutics plc finds support from accumulated volume at $1.75.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.09 between high and low, or 5.33%. For the last week, the stock has had a daily average volatility of 5.78%.
Our recommended stop-loss: $1.65 (-6.71%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 2 days ago.)
5.78 %Average volatility
Very Low Low Medium High Very High
Adaptimmune Therapeutics plc holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level, we recommend to hold or accumulate in this position whilst awaiting further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|ADAP $1.77 ($0.02 1.14%)|
ADAP is up $0.02 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ADAP based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ADAP analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!